Candel TherapeuticsCADL

13F holders, Q2 2024 (June 30)
45holders +25
30new positions
6sold out
2famous investors
$6.20avg. 13F price*

At the end of Q2 2024, 45 institutions reported holding Candel Therapeutics Inc. (CADL) in their 13F filings, up 25 from Q1 2024. 30 opened new positions and 6 sold out. The largest holders were Northpond Ventures, LLC ($12.0M), BlackRock Inc. ($5.1M) and Vanguard Group Inc. ($5.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Candel Therapeutics Inc.
CUSIP
137404109
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 20Q1 2024Q2 2024: 45Q2 2024Q3 2024: 52Q3 2024Q4 2024: 71Q4 2024Q1 2025: 82Q1 2025Q2 2025: 78Q2 2025Q3 2025: 81Q3 2025Q4 2025: 84Q4 2025Q1 2026: 114Q1 2026Q2 2026: 137Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions30$5.7M
Exits6$170K

All 13F filers, Q1 2024 → Q2 2024: 2,725,499 shares bought and 554,725 shares sold, net +2,170,774 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 45 holders

Northpond Ventures, LLC 21.71% No change 1,935,215 $12.0M
BlackRock Inc. 0.00% Add +1629.9% 823,071 $5.1M
Vanguard Group Inc. 0.00% Add +51.2% 818,550 $5.1M
State Street Corp. 0.00% Add +1613.0% 472,798 $2.9M
Sands Capital Alternatives, LLC 0.84% Reduce -50.0% 405,837 $2.5M
Geode Capital Management, LLC 0.00% Add +173.1% 397,886 $2.5M
Nuveen Asset Management, LLC 0.00% New 382,188 $2.4M
Bridgeway Capital Management, LLC 0.01% Reduce -2.4% 80,595 $500K
MML Investors Services, LLC 0.00% New 73,376 $455K
Bank of America Corp. 0.00% New 54,449 $338K
Bank of New York Mellon Corp 0.00% New 54,449 $338K
Charles Schwab Investment Management Inc. 0.00% New 46,777 $290K
Northern Trust Corp. 0.00% Add +122.7% 43,445 $269K
Cubist Systematic Strategies, LLC 0.00% New 26,121 $162K
Osaic Holdings, Inc. 0.00% New 25,800 $160K
Rhumbline Advisers 0.00% New 22,985 $143K
Virtu Financial LLC 0.01% New 22,639 $140K
Vontobel Holding Ltd. 0.00% New 22,000 $136K
Schonfeld Strategic Advisors LLC 0.00% New 21,452 $133K
Renaissance Technologies 0.00% Reduce -63.8% 20,600 $128K
Morgan Stanley 0.00% New 19,458 $121K
JPMorgan Chase & Co. 0.00% Add +8659.3% 19,358 $120K
Alpine Global Management, LLC 0.02% New 18,761 $116K
Goldman Sachs Group Inc. 0.00% New 18,225 $113K
Millennium Management 0.00% New 17,344 $108K
New York State Common Retirement Fund 0.00% New 17,000 $105K
Squarepoint Ops LLC 0.00% New 12,238 $76K
Jane Street Group, LLC 0.00% New 11,960 $74K
Janney Montgomery Scott LLC 0.00% New 11,615 $72K
Corebridge Financial, Inc. 0.00% — 10,660 $66K
Alliancebernstein L.P. 0.00% New 10,660 $66K
Barclays PLC 0.00% New 6,717 $42K
Wells Fargo & Company 0.00% Add +5416.5% 6,344 $39K
UBS Group AG 0.00% Add +59950.0% 6,005 $37K
Simplex Trading, LLC 0.00% New 5,001 $31K
Point72 (DIFC) Ltd 0.00% New 4,927 $31K
Citigroup Inc. 0.00% New 4,598 $29K
Royal Bank of Canada 0.00% Add +3181.2% 2,264 $15K
Legal & General Group Plc 0.00% New 2,197 $14K
Ameritas Investment Partners, Inc. 0.00% New 1,941 $12K
California State Teachers Retirement System 0.00% New 1,436 $9K
Tower Research Capital LLC (TRC) 0.00% Reduce -66.2% 1,252 $8K
Point72 Asia (Singapore) Pte. Ltd. 0.00% New 813 $5K
Amalgamated Bank 0.00% New 686 $4K
Deutsche Bank AG 0.00% New 68 $422

"% of holder's portfolio" is CADL's weight in each manager's 13F, not the share of Candel Therapeutics Inc. the manager owns.